ags67e
mAbexperimentalADC
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 14, 2014 (NCT02175433)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Leukocyte antigen CD37Supplementation
CD37 supplementation
Chemistry & pharmacology
- Multi-specific
- No
- Payload
- Monomethylauristatin E
Oral
No
Parenteral
No
Topical
No
Also known as
- ags67e
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02610062 | Phase 1 | Apr 4, 2016 | Agensys, Inc. |
| NCT02175433 | Phase 1 | Oct 14, 2014 | Agensys, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Agensys, Inc. | For profit | 2 | 2 | 1 | 2014 |
1 organizations
Page 1 / 1